Metabolic Differences of an Oral and Intravenous Dose of 3-hydroxybutyrate (3-OHB).
Sponsor: University of Aarhus
This NA trial investigates Healthy and Incretin Effect and is currently completed. University of Aarhus leads this study, which shows 6 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Dec 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Dec 2019 — Dec 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jun 2019 — Dec 2019 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .